Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
US Army
Cantor Fitzgerald
AstraZeneca
Farmers Insurance
UBS
Dow
Harvard Business School
McKinsey

Generated: July 18, 2018

DrugPatentWatch Database Preview

Glipizide - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for glipizide and what is the scope of glipizide freedom to operate?

Glipizide
is the generic ingredient in five branded drugs marketed by Aurobindo Pharma Ltd, Mylan Pharms Inc, Par Pharm, Unique Pharm Labs, Watson Labs, Pfizer, Accord Hlthcare, Ani Pharms Inc, Apotex, Barr Labs Inc, Mylan, Sandoz, Sun Pharm Inds Inc, Vintage Pharms Llc, Watson Labs Teva, Epic Pharma Llc, Heritage Pharms Inc, Teva Pharms, Zydus Pharms Usa Inc, and Bristol Myers Squibb, and is included in twenty-seven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Glipizide has twenty-four patent family members in nineteen countries.

There are eighteen drug master file entries for glipizide. Fifty-four suppliers are listed for this compound. There is one tentative approval for this compound.
Pharmacology for glipizide
Ingredient-typeSulfonylurea Compounds
Drug ClassSulfonylurea
Medical Subject Heading (MeSH) Categories for glipizide
Synonyms for glipizide
094G619
1-Cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)urea
1-cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea
1-cyclohexyl-3-(4-(2-(2-methylpyrazine-5-carboxamido)ethyl)phenylsulfonyl)urea
1-cyclohexyl-3-[[p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl]sulfonyl]urea
1-Cyclohexyl-3-{4-[2-(5-methylpyrazine-2-carboxamido)ethyl]phenylsulfonyl}urea
172964-66-8
29094-61-9
29094-66-4
38777-27-4
AB0012143
AC-15789
AC1L1G0Z
AC1Q2OG0
AKOS005564405
Aldiab
Alphapharm Brand of Glipizide
AN-15826
ANW-41980
API0002842
BBL028143
BC209538
BDBM50012956
BG0209
BIDD:GT0476
Bio-0161
Bio1_000074
Bio1_000563
Bio1_001052
Bio2_000069
Bio2_000549
BPBio1_000224
BRD-K12219985-001-04-8
BRN 0903495
BSPBio_000202
BSPBio_001349
C-22417
C21H27N5O4S
CAS-29094-61-9
CBiol_001788
CC-28982
CCG-204710
CHEBI:5384
CHEMBL1073
CP 28,720
CP 28720
CP-28,720
CP-28720
CPD000058455
CS-2239
CTK8B3212
D00335
D0Z4SB
DB01067
Digrin
Dipazide
DR002755
DSSTox_CID_20676
DSSTox_GSID_40676
DSSTox_RID_79535
DTXSID0040676
EINECS 249-427-6
EU-0100621
FT-0626714
FT-0659737
G-117
G0369
Glibenese
Glibenese Brand of Glipizide
Glibetin
Glican
Glide
Glidiab
Glidiazinamide
Glipid
Glipizibe
glipizid
Glipizida
Glipizida [INN-Spanish]
Glipizide (Glucotrol)
Glipizide (USP/INN)
Glipizide [USAN:BAN:INN]
Glipizide [USAN:USP:INN:BAN]
Glipizide Extended-Release Tablets
Glipizide Kenfarma Brand
Glipizide, European Pharmacopoeia (EP) Reference Standard
Glipizide, pharmaceutical secondary standard; traceable to USP, PhEur
Glipizide, solid
Glipizide, United States Pharmacopeia (USP) Reference Standard
Glipizidum
Glipizidum [INN-Latin]
Gluco-Rite
Glucolip
Glucotrol
Glucotrol (TN)
Glucotrol XL
Glucotrol XL, Glucotrol, Glipizide
Glucozide
Glupitel
Glupizide
Glyde
Glydiazinamide
Glypidizine
GTPL6821
HE332283
HMS1361D11
HMS1568K04
HMS1791D11
HMS1989D11
HMS2089C21
HMS2093J09
HMS2095K04
HMS2233N11
HMS3259K12
HMS3261N04
HMS3369L12
HMS3402D11
HMS3655G04
HY-B0254
I06-0186
I06-1985
IDI1_033819
K 4024
K-4024
K4024
KB-52251
KBio2_000069
KBio2_002637
KBio2_005205
KBio3_000137
KBio3_000138
KBioGR_000069
KBioSS_000069
Kenfarma Brand of Glipizide
KS-1068
Lacer Brand of Glipizide
Lilly Brand of Glipizide
Lopac-G-117
Lopac0_000621
LP00621
LS-159679
MCULE-5142805548
Melizide
Metaglip
Metaglip (Salt/Mix)
MFCD00072159
Mindiab
Minidab
Minidiab
Minodiab
MLS000069386
MLS001148176
MolPort-002-885-830
N-(2-[4-(([(Cyclohexylamino)carbonyl]amino)sulfonyl)phenyl]ethyl)-5-methyl-2-pyrazinecarboxamide
N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-5-methylpyrazine-2-carboxamide
N-(4-(.beta.-(5-Methylpyrazine-2-carboxamido)ethyl)benzenesulphonyl)-N'-cyclohexylurea
N-(4-(beta-(5-Methylpyrazine-2-carboxamido)ethyl)benzenesulphonyl)-N'-cyclohexylurea
N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-5-methylpyrazine-2-carboxamide
N-(4-[N-(cyclohexylcarbamoyl)sulfamoyl]phenethyl)-5-methylpyrazine-2-carboxamide
N-[2-(4-{[(cyclohexylamino)carbonylamino]sulfonyl}phenyl)ethyl](5-methylpyrazi n-2-yl)carboxamide
N-[2-(4-{[(cyclohexylcarbamoyl)amino]sulfonyl}phenyl)ethyl]-5-methylpyrazine-2-carboxamide
N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-pyrazine-2-carboxamide
N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide
N-[4-(3-Cyclohexylureidosulfonyl)phenethyl]-5-methyl-2-pyrazinecarboxamide
N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-N'-cyclohexylurea
Napizide
NC00564
NCGC00015462-01
NCGC00015462-02
NCGC00015462-03
NCGC00015462-04
NCGC00015462-05
NCGC00015462-06
NCGC00015462-07
NCGC00015462-08
NCGC00015462-09
NCGC00015462-10
NCGC00015462-11
NCGC00015462-12
NCGC00015462-14
NCGC00016802-01
NCGC00023748-03
NCGC00023748-04
NCGC00023748-05
NCGC00023748-06
NCGC00023748-07
NCGC00255522-01
NCGC00261306-01
NSC-759120
NSC759120
Opera_ID_1908
Ozidia
Pfizer Brand 2 of Glipizide
PfizerBrand 1 of Glipizide
Pharmakon1600-01505433
Prestwick_242
Prestwick0_000131
Prestwick1_000131
Prestwick2_000131
Prestwick3_000131
Pyrazinecarboxamide, N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-5-methyl-
Pyrazinecarboxamide, N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methyl-
s1715
SAM002564210
Samarium(III) ionophore I
SBI-0050603.P002
SC-13933
SCHEMBL17094
Semiglynase
SMR000058455
SPBio_002141
SR-01000000010
SR-01000000010-2
ST50826363
STK631952
Sucrazide
TC-063559
TK 1320
TL8006447
Tox21_110156
Tox21_110156_1
Tox21_301834
Tox21_500621
UNII-X7WDT95N5C
Urea, 1-cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)-
W-107005
X7WDT95N5C
Z1880962274
ZINC537795
ZJJXGWJIGJFDTL-UHFFFAOYSA-N
Tentative approvals for GLIPIZIDE
Applicant Application No. Strength Dosage Form
➤ Try a Free Trial➤ Try a Free Trial2.5MGTABLET, EXTENDED RELEASE;ORAL
➤ Try a Free Trial➤ Try a Free Trial10MGTABLET, EXTENDED RELEASE;ORAL
➤ Try a Free Trial➤ Try a Free Trial5MGTABLET, EXTENDED RELEASE;ORAL

US Patents and Regulatory Information for glipizide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc GLIPIZIDE glipizide TABLET;ORAL 074387-002 Mar 4, 1996 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan GLIPIZIDE AND METFORMIN HYDROCHLORIDE glipizide; metformin hydrochloride TABLET;ORAL 078083-003 Apr 12, 2007 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva Pharms GLIPIZIDE AND METFORMIN HYDROCHLORIDE glipizide; metformin hydrochloride TABLET;ORAL 077270-001 Oct 28, 2005 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan GLIPIZIDE glipizide TABLET;ORAL 074438-002 Jun 20, 1995 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for glipizide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-001 Apr 26, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-002 Apr 26, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-003 Aug 10, 1999 ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-003 Aug 10, 1999 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for glipizide

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,024,843 Oral hypoglycemic glipizide granulation ➤ Try a Free Trial
5,091,190 Delivery system for administration blood-glucose lowering drug ➤ Try a Free Trial
5,545,413 Dosage form for administering oral hypoglycemic glipizide ➤ Try a Free Trial
5,591,454 Method for lowering blood glucose ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Harvard Business School
AstraZeneca
Accenture
Argus Health
Queensland Health
Dow
Teva
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.